Suppr超能文献

无论是活菌还是死菌形式的普拉梭菌都能通过调节肠道菌群和短链脂肪酸生成来缓解屋尘螨诱导的变应性哮喘。

Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China.

School of Food Science and Technology, Jiangnan University, Wuxi, China.

出版信息

J Sci Food Agric. 2021 Oct;101(13):5563-5573. doi: 10.1002/jsfa.11207. Epub 2021 Apr 30.

Abstract

BACKGROUND

Asthma is increasingly prevalent worldwide, and novel strategies to prevent or treat this disease are needed. Probiotic intervention has recently been reported to be effective for asthma prevention. Here, we explored the effects of Faecalibacterium prausnitzii on the development of allergic airway inflammation in a murine model of house dust mite (HDM)-induced allergic asthma.

RESULTS

Supplementation with living and dead F. prausnitzii blocked eosinophil, neutrophil, lymphocyte and macrophage influx and alleviated the pathological changes. Moreover, both living and dead F. prausnitzii administration decreased the levels of interleukin (IL)-4, IL-5, IL-13 and immunoglobulin G1, elevated regulatory T cell (Tregs) ratio, improved microbial dysbiosis and enhanced short-chain fatty acid (SCFA) production. Network correlation analysis revealed that the immune indicators were strongly associated with SCFA production. Based on the linear discriminant analysis effect size, Turicibacter was found to be the core genus related to HDM-induced asthma. Living F. prausnitzii treatment enriched Faecalibaculum, Dubosiella and Streptococcus, while dead F. prausnitzii treatment increased Muribaculaceae and Parabacteroides. Interestingly, both living and dead F. prausnitzii administration enriched Lachnoclostridium and normalized the pathways involving carbohydrate and lipid metabolism, which might be related to SCFA production.

CONCLUSION

Faecalibacterium prausnitzii exerts an anti-asthmatic effect partly by gut microbiota modulation and SCFA production, suggesting its potential as a probiotic agent for allergic asthma prevention. © 2021 Society of Chemical Industry.

摘要

背景

哮喘在全球范围内的发病率日益增高,因此需要新的策略来预防或治疗这种疾病。最近有报道称益生菌干预对预防哮喘有效。在这里,我们探索了粪真杆菌对屋尘螨(HDM)诱导的过敏性哮喘小鼠模型中过敏性气道炎症发展的影响。

结果

补充活菌和死菌粪真杆菌可阻止嗜酸性粒细胞、中性粒细胞、淋巴细胞和巨噬细胞浸润,并缓解病变。此外,活菌和死菌粪真杆菌给药均降低白细胞介素(IL)-4、IL-5、IL-13 和免疫球蛋白 G1 的水平,增加调节性 T 细胞(Tregs)的比例,改善微生物失调并增强短链脂肪酸(SCFA)的产生。网络相关分析表明,免疫指标与 SCFA 产生密切相关。基于线性判别分析效应大小,Turicibacter 被发现是与 HDM 诱导的哮喘相关的核心属。活菌粪真杆菌治疗可使 Faecalibaculum、Dubosiella 和 Streptococcus 丰度增加,而死菌粪真杆菌治疗可使 Muribaculaceae 和 Parabacteroides 丰度增加。有趣的是,活菌和死菌粪真杆菌给药均增加 Lachnoclostridium 并使涉及碳水化合物和脂质代谢的途径正常化,这可能与 SCFA 的产生有关。

结论

粪真杆菌通过调节肠道微生物群和产生 SCFA 发挥抗哮喘作用,表明其作为预防过敏性哮喘的益生菌制剂的潜力。 © 2021 英国化学学会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验